Pembrolizumab for Hodgkin's Lymphoma User Reviews
Brand names: Keytruda
- joh...
- Taken for 1 to 2 years
- January 26, 2025
"Ending usage in a few months - apparently no use after that. For recurrent CHL and been on it for almost a couple of years, in an older gentleman. So far, so good, but no imaging since started. No lumps or bumps or any sign of recurrence. Side effects known include mild cramping and some itching sites."
- Jos...
- Taken for 1 to 6 months
- March 22, 2025
Pembrolizumab "No problems after 6 infusions. Previous prostate cancer led to removal of prostate. Check-up discovered non-Hodgkin's lymphoma. Melanoma discovered during lymphoma check-up. Have my fingers crossed on this one."
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Frequently asked questions
- Pembrolizumab vs. nivolumab: How do they compare?
- What type of cancer is pembrolizumab used for?
- How are Inlyta and Keytruda used in kidney cancer?
- How does pembrolizumab affect the immune system?
Are you taking this medicine?
Your review helps others make informed decisions.Learn more about Hodgkin's Lymphoma
Care guides
Symptoms and treatments
More about pembrolizumab
- Check interactions
- Compare alternatives
- Reviews (281)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Pembrolizumab "Recurrent Hodgkin lymphoma and Keytruda put me in remission immediately, first infusion. It is a miracle drug for many! However, side effects after 7 months of treatment were becoming unbearable and ceased. Skin and lung issues from first month. Been 3 months since stopping infusions and seem to be improving!"